2 most recent filings and news items mentioning PODD. Updated every 60 seconds.
LeadershipJun 25, 2026Neutral
Insulet announced Jonathan J. Mazelsky will join its Board as an independent director effective July 1, 2026. Mazelsky’s extensive background in healthcare innovation is expected to bolster the company's strategy for expanding Omnipod access and driving shareholder value.
View filing at SEC.gov →
RegulatoryMay 26, 2026Negative
Insulet Corporation announced a voluntary medical device correction for approximately 7 million Omnipod pods across multiple product lines due to a manufacturing defect causing potential insulin under-delivery, with 24 serious adverse events reported globally including hospitaliz
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.